Minneapolis, MNNCT06464029Now EnrollingIRB Ready

Parkinson Disease Clinical Trial in Minneapolis, MN

Access cutting-edge parkinson disease treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access parkinson disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related parkinson disease treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this parkinson disease clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Parkinson Disease Study in Minneapolis

The purpose of this project is to use transcranial magnetic stimulation (TMS) to explore the state of excitability of corticocortical and corticofugal (cortex to spinal cord, cortex to brainstem to spinal cord) pathways that project to muscles that control the legs and trunk in people with Parkinson's disease. The outcome variables will be further analyzed to understand their relationship to quantitative measures of postural instability and gait dysfunction. As such, the project can be classified as basic physiologic research. The protocol is not designed to determine if measures of corticocortical or corticofugal excitability can be used as a biomarker to predict disease progression.

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

Participants with Parkinson's disease
Diagnosis of idiopathic PD or dystonia as determined by a movement disorders neurologist in accordance with the UK Society Brain Bank diagnostic criteria.
Age 45-80 years.
Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters. Healthy Older Adults (Control participants)
Age 45-80 years (this group will be age and sex-matched to the PD group)
Able to ambulate independently without the use of an assistive device (cane or walker) Healthy Young Adults
Age 21-44 years (this group will be age and sex-matched to the PD group)
Able to ambulate independently without the use of an assistive device (cane or walker)

Exclusion Criteria

Subjects who describe a history of a frequent vasovagal syncope (fainting) in response to blood, emotional stress, or sensory triggers.
Subjects who are on anti-coagulant medications.
Any musculoskeletal disorder that affects the ability to stand.
History of seizures, epilepsy, stroke, multiple sclerosis, or traumatic brain injury.
Intracranial metallic or magnetic devices.
Pacemaker or any implanted device.
History of surgery on blood vessels, brain or heart.
Unexplained, recurring headaches or concussion within the last six months.
Moderate to severe hearing impairment.
Subjects who are pregnant.
Dementia diagnosis
Other significant neurological disorders that may affect participation or performance in the study
Implanted deep brain stimulator or other neurosurgeries to treat PD.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT06464029) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Parkinson Disease Treatment Options in Minneapolis, MN

If you're searching for parkinson disease treatment options in Minneapolis, MN, this clinical trial (NCT06464029) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all parkinson disease clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Minneapolis, MN

See all parkinsons disease clinical trials recruiting in Minneapolis — not just this study.

Browse Parkinsons Disease Trials in Minneapolis

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN